MiMedx Group Lowers FY2026 Sales Guidance from $340.000M-$360.000M to $260.000M-$290.000M vs $307.000M Est

Benzinga Newsdesk www.benzinga.com Negative 96.2%

Neg 96.2% Neu 0% Pos 0%

MiMedx Group (NASDAQ:MDXG) lowers FY2026 sales outlook from $340.000 million-$360.000 million to $260.000 million-$290.000 million vs $307.000 million estimate.